T he predominant physiological role of the renin-angiotensin system is to regulate blood pressure and water/ sodium homeostasis. Excessive angiotensin II (Ang II), the major bioactive angiotensin peptide of this system, leads to vascular dysfunction that contributes to many cardiovascular diseases. Increasing evidence supports a concept that overactivation of the renin-angiotensin system disrupts normal immune/inflammatory responses. Although this overview of adverse responses to Ang II is widely accepted, how alterations in inflammation contribute to vascular dysfunction is not completely understood.
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Alterations in immune responses to vascular function were reported >4 decades ago but less advancement in understanding how immune-mediated or inflammation-induced responses have been identified. 1 Recently, Guzik et al 2 reported that RAG-1 −/− mice, lacking both functional T and B lymphocytes, were protected from Ang II-induced loss of endothelium-dependent vasodilatation. Conversely, adoptive transfer of T lymphocytes led to vascular dysfunction that were attributed to impaired endothelium-dependent vasodilatation and an increase in vascular superoxide production in response to Ang II. The authors interpreted these findings as one mechanism of Ang II-induced high blood pressure. After this initial report, other groups have confirmed contribution of immune/inflammation to Ang IIinduced vascular dysfunction beyond hypertension. 3, 4 Various cytokines produced by inflammatory cells were reported to contribute to vascular dysfunction. Among multiple cytokines, one that has drawn attention is interferon-γ (IFN-γ). [5] [6] [7] In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Kossmann et al 8 have elucidated exciting findings that natural killer (NK) cells of the innate immune system by cross-talking with monocytes play a critical role in Ang II-induced vascular dysfunction by fueling the degree of vascular inflammation. The authors demonstrated that through a T-bet-dependent mechanism, interleukin 12 (IL-12) secreting monocytes stimulate NK cells to produce IFN-γ, thereby mediating Ang II-induced vascular dysfunction.
Why is this study so exciting? First, this study provides compelling evidence that IFN-γ produced by NK cells is an essential cytokine mediating Ang II-induced vascular inflammation and dysfunction. IFN-γ, an inflammatory cytokine exclusively produced by immune cells, such as NK cells, T lymphocytes, macrophages, and dendritic cells, is known to promote inflammatory responses. T-bet encoded by Tbx21 regulates IFNγ production in several different cell lineages. The study by Kossmann et al 8 clearly demonstrated that Ang II-induced inflammation (eg, expression of MCP-1 and MIP-1) and vascular dysfunction are largely protected in Tbx21 −/− and IFN-γ −/− mice, whereas overexpression of IFN-γ in transgenic serum amyloid P component-IFN-γ mice led to vascular dysfunction. Consistent with findings from this study, studies from us and others have also demonstrated that mice with deficiency of IFN-γ or its receptor are largely protected from Ang II-driven cardiac or renal pathology. 5, 7 In contrast, there is a report that deficiency of IFN-γ in mice augments Ang II-induced aortic pathology. 9 Therefore, effects of IFN-γ and its targeting sites remain to be clarified in cardiovascular pathologies.
Kossmann et al 8 also demonstrated that one source of IFN-γ production, NK cells, were required for the initiation of Ang II-induced vascular dysfunction. When NK cells (NK1.1 + TCRβ − ) were depleted by monoclonal NK1.1specific antibody, Ang II-induced vascular dysfunction was significantly attenuated. However, because adoptive transfer of IFN-γ competent NK cells into Tbx21 −/− mice could not re-establish Ang II-induced vascular dysfunction, there must be other inflammatory cells and their related inflammatory responses required for this Ang II-induced vascular dysfunction. Indeed, previous studies by the same group and others observed that inflammatory cells of the myelomonocytic lineage, such as macrophages, promote Ang II-induced vascular dysfunction mainly through phagocyte-type NADPH oxidase-driven reactive oxygen species formation and inducible NO synthase activity. 4, 10 It is well established that multiple inflammatory cell types and multiple cytokines are involved in Ang II-induced vascular dysfunction. The study by Kossmann et al 8 identified a critical role of T-bet in stimulating IL-12 expression in myelomonocytic cells, which led to recruitment and activation of NK cells into arterial wall. Infiltrated NK cells engaged with monocytes in inflammatory sites leading to mutual activation. Two previous studies have shown that NK cell-derived IFN-γ activates monocytes into macrophages and dendritic cells that produce IL-12 and IL-18. 11, 12 In turn, IL-12 synergizes with IL-18 in stimulating IFN-γ production in NK cells to initiate inflammation. 11, 12 In agreement with these 2 studies, Kossmann et al 8 also provided evidence that T-bet not only regulated IFN-γ expression in NK cells but also has an important role in stimulating IL-12 expression in T-bet + CD11b + myelomonocytic cells (Figure) .
Altogether, Kossman et al 8 have provided evidence that NK cells contribute to Ang II-induced vascular dysfunction by infiltrating vessels, producing IFN-γ, and communicating with myeolomonocytes. T-bet stimulates vascular NK cell recruitment and monocyte activation in response to Ang II (Figure) . However, as this study noted, because deficiency in either T-bet or IFN-γ only led to partial attenuation of Ang II-induced vascular dysfunction, studies are needed to understand how integrated inflammatory programs regulate Ang II-induced vascular dysfunction. For example, how are reciprocal integrations among different lymphocytes, macrophages, and NK cells engaged in vascular dysfunction? How does interplay among inflammatory cytokines participate in vascular dysfunction? Nevertheless, this excellent report provides new mechanistic insights and thus is enhancing our knowledge on immune/inflammatory-related mechanisms of Ang II-induced vascular dysfunction.
Figure.
Angiotensin II (Ang II)-induced vascular dysfunction depends on interferon (IFN)-γ production by natural killer (NK) cells. Ang II increases infiltration of CD11b + T bet + myelomonocytic cells and NK1 1 + T bet + NK cells into aorta. Interleukin (IL)-12 expressed by myelomonocytic cells stimulates IFN-γ production by NK cells in vascular wall. This reciprocal activation leads to vascular inflammation and dysfunction. TCR indicates T-cell receptor.
